These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 400274)

  • 1. The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemicity, and disappearance.
    Nathanson N; Martin JR
    Am J Epidemiol; 1979 Dec; 110(6):672-92. PubMed ID: 400274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eradication of poliomyelitis in the United States.
    Nathanson N
    Rev Infect Dis; 1982; 4(5):940-50. PubMed ID: 7146731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects for the eradication of infectious diseases.
    Stuart-Harris C
    Rev Infect Dis; 1984; 6(3):405-11. PubMed ID: 6377445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From emergence to eradication: the epidemiology of poliomyelitis deconstructed.
    Nathanson N; Kew OM
    Am J Epidemiol; 2010 Dec; 172(11):1213-29. PubMed ID: 20978089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization against poliomyelitis: risk/benefit/cost in a changing context.
    Salk J
    Dev Biol Stand; 1979; 43():151-7. PubMed ID: 230106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herd effect and virus eradication with use of killed poliovirus vaccine.
    Salk D
    Dev Biol Stand; 1981; 47():247-55. PubMed ID: 6262150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of paralytic poliomyelitis in the United States.
    Schonberger LB; Kaplan J; Kim-Farley R; Moore M; Eddins DL; Hatch M
    Rev Infect Dis; 1984; 6 Suppl 2():S424-6. PubMed ID: 6740085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eradication of indigenous poliomyelitis in Canada: impact of immunization strategies.
    Varughese PV; Carter AO; Acres SE; Furesz J
    Can J Public Health; 1989; 80(5):363-8. PubMed ID: 2804867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Worldwide eradication of poliomyelitis].
    Rasch G; Schreier E; Kiehl W; Kurth R
    Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eradication of poliomyelitis in the United States. II. Experience with killed poliovirus vaccine.
    Salk D
    Rev Infect Dis; 1980; 2(2):243-57. PubMed ID: 6771867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eradication of poliomyelitis in the United States. III. Poliovaccines--practical considerations.
    Salk D
    Rev Infect Dis; 1980; 2(2):258-73. PubMed ID: 6994208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance and control of poliomyelitis in The Netherlands.
    Bijkerk H
    Rev Infect Dis; 1984; 6 Suppl 2():S451-6. PubMed ID: 6330840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.
    Pliaka V; Kyriakopoulou Z; Markoulatos P
    Expert Rev Vaccines; 2012 May; 11(5):609-28. PubMed ID: 22827246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of paralytic poliomyelitis in the United States. 1966 and 1967 cases, and 1965-1967 cases associated with oral poliovirus vaccine.
    Hopkins CC; Dismukes WE; Glick TH; Warren RJ
    JAMA; 1969 Oct; 210(4):694-700. PubMed ID: 4309925
    [No Abstract]   [Full Text] [Related]  

  • 18. Paralytic poliomyelitis in the Gaza Strip and West Bank during recent years.
    Gerichter CB; Lasch EE; Sever I; el-Massri M; Skalska P
    Dev Biol Stand; 1978; 41():173-7. PubMed ID: 753648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A developing country perspective on vaccine-associated paralytic poliomyelitis.
    John TJ
    Bull World Health Organ; 2004 Jan; 82(1):53-7; discussion 57-8. PubMed ID: 15106301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiologic aspects of poliomyelitis eradication.
    Nathanson N
    Rev Infect Dis; 1984; 6 Suppl 2():S308-12. PubMed ID: 6740065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.